Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

No current evidence for risk of vaccine-driven virulence evolution in SARS-CoV-2

View ORCID ProfileIan F. Miller, C. Jessica E. Metcalf
doi: https://doi.org/10.1101/2020.12.01.20241836
Ian F. Miller
1Department of Ecology and Evolutionary Biology, Princeton University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ian F. Miller
  • For correspondence: ifmiller@princeton.edu
C. Jessica E. Metcalf
1Department of Ecology and Evolutionary Biology, Princeton University
2Priceton School of Public and International Affairs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Vaccines that reduce clinical severity but not infection or transmission could drive the evolution of increased rates of pathogen-inflicted damage, or virulence. Preliminary evidence suggests that COVID-19 vaccines might have such differential effects, conferring greater protection in the lower respiratory tract, where viral growth most impacts severity, than in the upper respiratory tract, where infection is chiefly determined. However, the evolution of increased virulence can only occur under certain conditions, which include the existence of a positive association between transmission and severity linked to viral genetic variation. Here, we review the current evidence for these conditions, which does not point to a risk of vaccine driven virulence evolution. An evo-epidemiological model also indicates that upper respiratory tract protection can minimize or negate selection for increased virulence should these conditions be met. Despite low apparent risks, SARS-CoV-2 virulence should be monitored, and transmission-limiting characteristics should be prioritized for ‘second-wave’ vaccines.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

IFM is supported by a NSF Graduate Research Fellowship.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

n/a

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All code used to perform the analyses presented in this manuscript is available on GitHub.

https://github.com/ianfmiller/covid_vaccines_virulence_evolution

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
No current evidence for risk of vaccine-driven virulence evolution in SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
No current evidence for risk of vaccine-driven virulence evolution in SARS-CoV-2
Ian F. Miller, C. Jessica E. Metcalf
medRxiv 2020.12.01.20241836; doi: https://doi.org/10.1101/2020.12.01.20241836
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
No current evidence for risk of vaccine-driven virulence evolution in SARS-CoV-2
Ian F. Miller, C. Jessica E. Metcalf
medRxiv 2020.12.01.20241836; doi: https://doi.org/10.1101/2020.12.01.20241836

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (521)
  • Anesthesia (124)
  • Cardiovascular Medicine (1417)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10286)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2625)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1729)
  • Health Policy (789)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12083)
  • Intensive Care and Critical Care Medicine (648)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2455)
  • Nursing (144)
  • Nutrition (377)
  • Obstetrics and Gynecology (490)
  • Occupational and Environmental Health (566)
  • Oncology (1318)
  • Ophthalmology (400)
  • Orthopedics (146)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (778)
  • Pharmacology and Therapeutics (329)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2394)
  • Public and Global Health (4998)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (255)
  • Sports Medicine (244)
  • Surgery (297)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)